|
US2019183813A1
|
|
Therapeutic compositions for treating pancreatic cancer
|
|
AU2018247249A1
|
|
Therapeutic compositions for treating pancreatic cancer
|
|
CN110088073A
|
|
For treating the method and composition of atopic dermatitis
|
|
KR20190008315A
|
|
Methods and compositions for treating advanced stage non-small cell lung cancer
|
|
CN109069448A
|
|
For treating the composition and method of liver cancer
|
|
US2016237012A1
|
|
Anticancer agents and process of making thereof
|
|
US2017049834A1
|
|
Benign prostatic hyperplasia add-on therapy
|
|
ZA201406549B
|
|
Methods and compositions for treating arteriosclerotic vascular diseases
|
|
US2015018296A1
|
|
Therapeutic methods and compositions utilizing cyclohexenone compounds
|
|
TW201446240A
|
|
Methods and compositions for treating leukemia
|
|
TW201500330A
|
|
Cyclohexenone compositions and process for making thereof
|
|
CN104968339A
|
|
Methods and compositions for treating neurodegenerative diseases
|
|
CN103948577A
|
|
Use of compound for preparing component for curing, alleviating or removing pain of bone cancer
|
|
WO2013192114A1
|
|
Methods and compositions for treating arteriosclerotic vascular diseases
|
|
TN2013000114A1
|
|
Methods and compositions for treating lung cancer
|
|
US2013203861A1
|
|
Methods and compositions for treating ovarian cancer
|
|
US2014274979A1
|
|
Method for the treatment of fatty liver disease
|
|
FR2987264A1
|
|
Methods and compositions for the treatment of cancer metastases
|
|
US2013172424A1
|
|
Methods and compositions for treating diabetes
|
|
CA2795586A1
|
|
Methods and compositions for treatment, modification and management of bone cancer pain
|
